Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

48,591 studies found

Active Not Recruiting
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the...

Conditions: Metastatic Castration-Resistant Prostate Cancer

City of Hope /ID# 262059 Duarte California

View details
Active Not Recruiting
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastat...

Conditions: Breast Carcinoma, Carcinoma of Unknown Primary, Endometrial Carcinoma, Esophagea...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Active Not Recruiting
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With...

Conditions: Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metas...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratin...

Conditions: Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma, Stage...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastati...

Conditions: Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer, Squa...

Research Site Duarte California

View details
Active Not Recruiting
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treat...

Conditions: Secondary Myelofibrosis

City of Hope Medical Center Duarte California

View details
Recruiting
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutane...

Conditions: Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lympho...

City of Hope Medical Center Duarte California

View details
Active Not Recruiting
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal C...

Conditions: Colorectal Cancer, Colorectal Cancer Metastatic

City of Hope Duarte California

View details
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Conditions: Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse La...

City of Hope Duarte California

View details
Recruiting
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients Wit...

Conditions: High Grade Sarcoma, Sarcoma

City of Hope Medical Center Duarte California

View details
Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Pre...

Conditions: Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostat...

City of Hope Duarte California

View details
Recruiting
Individualized AML Treatment

Conditions: Relapsed/Refractory Acute Myeloid Leukemia (AML)

City of Hope Medical Center Duarte California

View details
Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lympho...

Conditions: Hodgkin Lymphoma, Relapsed or Refractory Hodgkin Lymphoma

City of Hope Cancer Center (Data Collection Only) Duart...

View details
Active Not Recruiting
Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based T...

Conditions: Neuroendocrine Neoplasm

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Recruiting
Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for...

Conditions: Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma, IDH-Wildtype

City of Hope Medical Center Duarte California

View details
Recruiting
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent He...

Conditions: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Active Not Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy i...

Conditions: Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Active Not Recruiting
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhanc...

Conditions: Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplas...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Recruiting
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atez...

Conditions: Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Active Not Recruiting
Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-I...

Conditions: Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymph...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recur...

Conditions: Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3...

City of Hope Comprehensive Cancer Center Duarte Califor...

View details
Recruiting
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Can...

Conditions: Localized Clear Cell Renal Cell Carcinoma, Resectable Clear Cell Renal Cell Carc...

City of Hope Medical Center Duarte California

View details
Active Not Recruiting
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Conditions: Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma

City of Hope Duarte California

View details
Recruiting
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell...

Conditions: Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Rena...

City of Hope Medical Center Duarte California

View details